Tag: mantle cell lymphoma treatment

Acalabrutinib wins US FDA approval for mantle cell lymphoma treatment

pharmanewsdaily- November 1, 2017

Acalabrutinib FDA approval : AstraZeneca has secured an early approval for its blood cancer drug Calquence (acalabrutinib) for the treatment of mantle cell lymphoma in ... Read More